Evidence map›Paper›PMID 39406991›Full record

ArticleDiscover oncology2024

Development trends and knowledge framework of artificial intelligence (AI) applications in oncology by years: a bibliometric analysis from 1992 to 2022.

Murat Koçak, Zafer Akçalı

Abstract read
In one paragraph

Article in Discover oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Bibliometric analysis of oncology communication from 1976 to 2025: a focus on narrative medicine.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Murat KoçakDepartment of Medical Informatics, Faculty of Medicine, Baskent University, Taşkent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11, 06490, Bahçelievler, Ankara, Turkey. muratkocak25@gmail.com.ORCID http://orcid.org/0000-0001-6510-3666
Zafer AkçalıDepartment of Medical Informatics, Faculty of Medicine, Baskent University, Taşkent Caddesi (Eski 1. Cadde) 77. Sokak (Eski 16. Sokak) No:11, 06490, Bahçelievler, Ankara, Turkey.ORCID http://orcid.org/0000-0003-2473-4431

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeOncology is the primary field in medicine with a high rate of artificial intelligence (AI) use. Thus, this study aimed to investigate the trends of AI in oncology, evaluating the bibliographic characteristics of articles. We evaluated the related research on the knowledge framework of Artificial Intelligence (AI) applications in Oncology through bibliometrics analysis and explored the research hotspots and current status from 1992 to 2022.

methodsThe research employed a scientometric methodology and leveraged scientific visualization tools such as Bibliometrix R Package Software, VOSviewer, and Litmaps for comprehensive data analysis. Scientific AI-related publications in oncology were retrieved from the Web of Science (WoS) and InCites from 1992 to 2022.

resultsA total of 7,815 articles authored by 35,098 authors and published in 1,492 journals were included in the final analysis. The most prolific authors were Esteva A (citaition = 5,821) and Gillies RJ (citaition = 4288). The most active institutions were the Chinese Academy of Science and Harward University. The leading journals were Frontiers ın Oncology and Scientific Reports. The most Frequent Author Keywords are "machine learning", "deep learning," "radiomics", "breast cancer", "melanoma" and "artificial intelligence," which are the research hotspots in this field. A total of 10,866 Authors' keywords were investigated. The average number of citations per document is 23. After 2015, the number of publications proliferated.

conclusionThe investigation of Artificial Intelligence (AI) applications in the field of Oncology is still in its early phases especially for genomics, proteomics, and clinicomics, with extensive studies focused on biology, diagnosis, treatment, and cancer risk assessment. This bibliometric analysis offered valuable perspectives into AI's role in Oncology research, shedding light on emerging research paths. Notably, a significant portion of these publications originated from developed nations. These findings could prove beneficial for both researchers and policymakers seeking to navigate this field.

Indexed as

Artificial intelligenceCancerDeep learningNeural networkOncology

Identifiers

PMID39406991
PMCPMC11480271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.